BOLD
Price:
$1.1
Market Cap:
$24.62M
Boundless Bio, Inc., a clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by targeting extrachromosomal DNA. Its lead product candidate is BBI-355, an oral inhibitor of checkpoint kinase 1 that is in Phase 1/2 clinical trial in patients with oncogene amplified cancers. The company is also developing BBI-825, an oral inhibitor of ribonucleotide reductase, which is in Phase 1/2 clinical trial in cancer patients with resistance gene amplifications; and ecDTx 3 program targeting a kinesin involved with the cellular mechanism for segregation of ecDNA. Boundless Bio, Inc. was formerly known as Pretzel Therapeutics, Inc...[Read more]
Industry
Biotechnology
IPO Date
2016-07-20
Stock Exchange
NASDAQ
Ticker
BOLD
According to Boundless Bio, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 14.08. This represents a change of -22.04% compared to the average of 18.06 of the last 4 quarters.
The mean historical Current Ratio of Boundless Bio, Inc. over the last ten years is 13.47. The current 14.08 Current Ratio has changed 10.35% with respect to the historical average. Over the past ten years (40 quarters), BOLD's Current Ratio was at its highest in in the March 2025 quarter at 22.15. The Current Ratio was at its lowest in in the September 2022 quarter at 0.
Average
13.47
Median
13.27
Minimum
7.74
Maximum
19.28
Discovering the peaks and valleys of Boundless Bio, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 127.51%
Maximum Annual Current Ratio = 19.28
Minimum Annual Increase = -54.35%
Minimum Annual Current Ratio = 7.74
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 18.98 | 43.01% |
| 2023 | 13.27 | 50.74% |
| 2022 | 8.80 | -54.35% |
| 2021 | 19.28 | 9.57% |
| 2018 | 17.60 | 127.51% |
| 2017 | 7.74 | -10.40% |
The current Current Ratio of Boundless Bio, Inc. (BOLD) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
13.68
5-year avg
15.59
10-year avg
13.47
Boundless Bio, Inc.’s Current Ratio is greater than Q32 Bio Inc. (4.57), greater than NextCure, Inc. (3.71), greater than Plus Therapeutics, Inc. (1.29), greater than Intensity Therapeutics, Inc. (3.60), greater than Iterum Therapeutics plc (2.13), less than AN2 Therapeutics, Inc. (31.96), greater than Pluri Inc. (4.81), greater than Rallybio Corporation (9.98), greater than Sonnet BioTherapeutics Holdings, Inc. (0.26), less than TAO Synergies Inc. (20.51),
| Company | Current Ratio | Market cap |
|---|---|---|
| 4.57 | $44.54M | |
| 3.71 | $34.11M | |
| 1.29 | $39.62M | |
| 3.60 | $21.70M | |
| 2.13 | $21.14M | |
| 31.96 | $29.18M | |
| 4.81 | $23.49M | |
| 9.98 | $28.16M | |
| 0.26 | $8.43M | |
| 20.51 | $23.26M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Boundless Bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Boundless Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Boundless Bio, Inc.'s Current Ratio?
How is the Current Ratio calculated for Boundless Bio, Inc. (BOLD)?
What is the highest Current Ratio for Boundless Bio, Inc. (BOLD)?
What is the 3-year average Current Ratio for Boundless Bio, Inc. (BOLD)?
What is the 5-year average Current Ratio for Boundless Bio, Inc. (BOLD)?
How does the current Current Ratio for Boundless Bio, Inc. (BOLD) compare to its historical average?